Literature DB >> 6186812

Synthesis of partially modified retro-inverso substance P analogues and their biological activity.

M Chorev, E Rubini, C Gilon, U Wormser, Z Selinger.   

Abstract

Partial retro-inverso modification of a single peptide bond was applied to pGlu-Phe-Phe-Gly-Leu-Met-NH2 (I), a C-terminal hexapeptide analogue of the neuropeptide substance P. Two analogues with reversed peptide bonds, between the pGlu-Phe and Phe-Gly residues, were prepared, purified and characterized. The analogue gpGlu-(RS)-mPhe-Phe-Gly-Leu-Met-NH2 (II) was devoid of either agonistic or antagonistic activity. The second pseudopeptide analogue, i.e., pGlu-Phe-gPhe-mGly-Leu-Met-NH2 (III), was found to be a full agonist with 22% of the potency of I in the guinea pig ileum assay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186812     DOI: 10.1021/jm00356a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Effect of substance P on rat gastrointestinal transit.

Authors:  P Silkoff; F Karmeli; E Goldin; A Ewenson; C Gilon; M Chorev; R Laufer; Z Selinger; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

2.  A multicomponent approach to the synthesis of 1,3-dicarbonylic compounds.

Authors:  Ana G Neo; Rosa M Carrillo; Jose Delgado; Stefano Marcaccini; Carlos F Marcos
Journal:  Mol Divers       Date:  2010-09-03       Impact factor: 2.943

3.  Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.

Authors:  G Guichard; N Benkirane; G Zeder-Lutz; M H van Regenmortel; J P Briand; S Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

4.  Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Authors:  Maria Vincenza Carriero; Katia Bifulco; Vincenzo Ingangi; Susan Costantini; Giovanni Botti; Concetta Ragone; Michele Minopoli; Maria Letizia Motti; Domenica Rea; Giosuè Scognamiglio; Gerardo Botti; Claudio Arra; Gennaro Ciliberto; Antonello Pessi
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.